Clinical trials
Osteoporosis clinical trials
Below are recruiting osteoporosis clinical trials, each written for real people, not researchers. We’re tracking 129 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06379243Recruiting
Predicting future spinal fractures after osteoporosis treatment
This study is testing a new way to predict if your spine might break again after you have treatment for a fracture caused by osteoporosis. If you have a recent spinal fracture from weak bones and are getting a cement injection (PVP or PKP), researchers want to check your information to see how well their risk model works for people like you.
Guangzhou, GuangdongAges 50–90 - NCT06395883Recruiting
Steroids and Your Bones in Joint Disease
This study looks at how steroids affect bone health in people with inflammatory joint diseases like rheumatoid arthritis. Researchers will track markers in your blood to see if short-term steroid use impacts your bones.
DrammenAges 25–90 - NCT06462833Recruiting
Health literacy and exercise in postmenopausal osteoporosis
This study looks at how understanding health information affects exercise and taking medicine correctly in women with osteoporosis after menopause. It aims to help improve bone health.
Ankara, YenimahalleAges 45 years+ - NCT06558188RecruitingPhase 4
Combined bone-building therapy for osteoporosis
This study tests a combination of two bone-building drugs (romosozumab and teriparatide) in postmenopausal women with osteoporosis who are at high risk for fractures. The goal is to see if the combination strengthens bones faster and better than either drug alone.
Boston, MassachusettsAges 45 years+ - NCT06655701Recruiting
Bladder leaks and muscle loss in postmenopausal women with bone thinning
This study looks at whether women with osteoporosis (thin bones) after menopause also have bladder leaks and loss of muscle mass. It may help understand links between these conditions.
IstanbulAges 50–75 - NCT06767150RecruitingPhase 4
Bone treatment after stopping denosumab for osteoporosis
This trial tests whether giving zoledronic acid (a bone-strengthening infusion) right after stopping denosumab can help prevent bone loss in women with post-menopausal osteoporosis. It may be a good option if you have finished at least 2 years of denosumab and your doctor says it's safe to stop.
AmiensAges 18 years+ - NCT06864130RecruitingPhase 4
Stopping Alendronate in osteoporosis after no fractures
This study wants to see if it is safe for postmenopausal women with osteoporosis to stop taking Alendronate after a long period of treatment without any new fractures. If you have been on Alendronate for a while and have stayed fracture-free, you may be able to take a break from the medicine.
AalborgAges Any age - NCT06947213Recruiting
Orthorexia nervosa in women with postmenopausal osteoporosis
This study looks at whether women with osteoporosis after menopause have a higher risk of orthorexia nervosa, an unhealthy obsession with healthy eating. It aims to compare women with and without osteoporosis to understand the connection.
IstanbulAges 55–75 - NCT07030205Recruiting
Brain imaging study for women with osteoporosis
This study uses brain scans (MRI) to look at how the brain might be linked to bone health in women with osteoporosis. It compares women with osteoporosis to healthy women of the same age.
Clermont-FerrandAges 50 years+ - NCT07067827Recruiting
Osteoporosis survey for clinic patients
This trial tests a self-questionnaire for people with osteoporosis who are already being followed at certain clinics. It aims to see if the questionnaire helps manage the condition.
Québec, QuebecAges 18 years+ - NCT07105163Recruiting
Bisphosphonate and supplement adherence in postmenopausal osteoporosis
This trial looks at how well women with postmenopausal osteoporosis follow their treatment plan, which includes a bisphosphonate taken once a week or once a month along with daily calcium and vitamin D supplements. The goal is to understand patterns that may help improve care.
Santiago de Compostela, A coruñaAges Any age - NCT07281586RecruitingPhase 4
Switching from Prolia to a different osteoporosis drug
This trial tests if it's safe to switch from a long-term osteoporosis medication called Prolia to another treatment. It may help women and men who have been on Prolia for at least 3 years.
Douliu, TaiwanAges 50–85 - NCT07283887RecruitingPhase 4
Romosozumab and Denosumab for Postmenopausal Osteoporosis
This trial compares two osteoporosis drugs (romosozumab and denosumab) given alone or together to see which works better for improving bone density. It may help if you are a postmenopausal woman with osteoporosis and have not taken strong bone medications recently.
Douliu, TaiwanAges 50–80 - NCT07303166Recruiting
Osteoporosis care decisions for frail elderly patients
This study learns from doctors in Alsace who treat osteoporosis in frail older patients. It aims to understand what helps or hinders their use of a practical guide. If you are a doctor who has used this guide, your insights could improve future care.
StrasbourgAges 18 years+ - NCT02635022Recruiting
Care plan plus bone-medicine monitoring after a fracture
This study tests a structured care service to help people manage osteoporosis after a new bone fragility fracture. It aims to improve how you take bone-protecting medicines and to make sure treatment is followed and monitored over time.
HsinchuAges 50 years+ - NCT02719314Recruiting
Study bone loss from steroid use in people with inflammatory disease
This study looks at how steroid medicines (called glucocorticoids) affect bone strength in people with long-term inflammatory rheumatic conditions or psoriasis. It may help improve how doctors check and manage osteoporosis risk and bone metabolism over time.
BerlinAges 18 years+ - NCT07677072Recruiting
Studying a blood protein to detect hidden bone fragility
This study looks at a protein called lumican in the blood to see if it can help find women who have fragile bones even if their bone density test looks normal. It's for postmenopausal women who are already getting a bone density scan as part of their routine care.
Küçükçekmece, IstanbulAges 45 years+ - NCT07419451Recruiting
Bone health and health knowledge study for older adults
This study looks at how much older adults know about osteoporosis and their overall health understanding. It aims to help improve education and awareness about bone health in aging.
Balıkesir, BandırmaAges 65 years+ - NCT07421713Recruiting
AI and chest x-rays to screen for osteoporosis
This trial tests if an AI software can use a chest x-ray to screen for osteoporosis, compared to the standard DXA bone density scan. It may offer a faster, simpler way to check bone health in people 50 and older.
RotterdamAges 50 years+ - NCT07616401Recruiting
Bone-Strengthening Drugs and Biomarkers in Postmenopausal Osteoporosis
This study tests two injectable medications (romosozumab and abaloparatide) that help strengthen bones in women after menopause. Researchers will also look at blood markers to understand why some women respond better to treatment than others.
Miano, LombardyAges 50 years+ - NCT07620834Recruiting
AI-Guided Bone Density Screening for High-Risk Adults
This study tests whether artificial intelligence can help identify people at risk for weak bones (osteoporosis) using chest X-rays. If you qualify, you'll be randomly assigned to either standard screening or AI-enhanced screening to see which approach works better.
ChanghuaAges 40–80 - NCT07621679Recruiting
Walking Program to Prevent Falls and Fractures in Older Adults
This study tests whether a specialized walking and balance program helps people aged 70+ with weak bones reduce their risk of falls and fractures. The program is designed to improve strength, balance, and confidence in daily movement.
Montreal, QuebecAges 70 years+ - NCT06264609Enrolling by invitationPhase 4
Precision follow-up study for osteoporosis treatment
This study is a follow-up for people who completed a previous precision medicine trial for osteoporosis. It will monitor your bone health to see how well the treatment is working over time.
Lexington, KentuckyAges 45 years+ - NCT04704947RecruitingPhase 3
Beta blockers and fracture risk in osteoporosis
This study tests whether using beta blocker blood pressure medicines affects the risk of fractures in people with osteoporosis. It may help doctors understand which medication choices lower fracture risk.
TantaAges 50 years+
Hear when a new Osteoporosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for osteoporosis?
- Yes. Clin2 currently lists 129 recruiting osteoporosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a osteoporosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a osteoporosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.